News & Events

2/28/2008Nimbus changes name to Sovicell and launches new website2/20/2008Sovicell announces winner of the iPod raffle1/25/2008Presentation of first validation data for the TRANSIL blood-to-brain absorption kit at the predictive human toxicity/ADME-Tox meeting in Brussels9/1/2007Release of TRANSIL Blood-to-Brain absorption kit

News & Events

News

Below is a listing of the latest news releases from Sovicell. Interviews and other media inquiries should be arranged by contacting Sonja Trog +49 341 520 44 0. E-mail us.

Thursday, February 28, 2008

Nimbus changes name to Sovicell and launches new website

Download the PDF to read more.

Wednesday, February 20, 2008

Sovicell announces winner of the iPod raffle

Congratulations to the winner of the iPod raffle held at the ADME-Tox Europe meeting in Stockholm! His name is Dr. Markus Probst.

Friday, January 25, 2008

Presentation of first validation data for the TRANSIL blood-to-brain absorption kit at the predictive human toxicity/ADME-Tox meeting in Brussels

The TRANSIL blood-to-brain absorption kit can be used both to assess the ability of compounds to permeate the blood brain barrier and to predict the equilibrium distribution of compounds between blood and brain. Using a structurally rather diverse test set of drugs it is shown that the test kit’s predictions correlate strongly with in vivo data.

Saturday, September 01, 2007

Release of TRANSIL Blood-to-Brain absorption kit

Nimbus Biotechnology brings the first ready-to-use assay kit for analyzing drug candidates ability to cross the blood brain barrier to the market.